Furthermore, the generation of induced Pluripotent Stem (iPS) cells from an
individual RP
patient would enable the large - scale production of the cell types
affected by the
patient's disease.
«
By creating a personalized
Patient - on - a-Chip, we can really begin to understand how diseases, medicines, chemicals, and foods affect an individual's health,» said Geraldine A. Hamilton, PhD, president and chief scientific officer of Emulate, Inc. «The goal of Emulate working with Cedars - Sinai is to advance and qualify the system for new clinical applications and ultimately democratize the technology so that it can have a broad impact on patient healthcare.
Patient - on - a-Chip, we can really begin to understand how diseases, medicines, chemicals, and foods
affect an
individual's health,» said Geraldine A. Hamilton, PhD, president and chief scientific officer of Emulate, Inc. «The goal of Emulate working with Cedars - Sinai is to advance and qualify the system for new clinical applications and ultimately democratize the technology so that it can have a broad impact on
patient healthcare.
patient healthcare.»
Gittleman tells us that
individuals affected by chronic bacterial infections are found to have copper that's low or unavailable, while conditions of chronic viral infection are more typically connected with low zinc and high copper levels.56 Such
patients often struggle on for years with little improvement, but may benefit from a copper - balancing program.57